1-2 of 2
Jose Zijlstra, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dose-Intensified Combined Modality Treatment with 2 Cycles of BEACOPP Escalated Followed by 2 Cycles of ABVD and Involved Field Radiotherapy (IF-RT) Is Superior to 4 Cycles of ABVD and IFRT in Patients with Early Unfavourable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG) HD14 Trial

Peter Borchmann, Andreas Engert, Annette Pluetschow, Michael Fuchs, Jana Markova, Andreas Lohri, Zdenek Kral, Richard Greil, Max Topp, Matthias Villalobos, Jose Zijlstra, MD, Martin Soekler, Harald Stein, Hans Theodor Eich, Rolf Peter Mueller, Volker Diehl
Journal: Blood
Blood (2008) 112 (11): 367.
https://doi.org/10.1182/blood.V112.11.367.367
Published: 2008
Journal Articles

First Report of the HOVON 45: A Phase II Study with Rituximab, High Dose Ara-C and Autologous Stem Cell Transplantation in the Primary Treatment of Mantle Cell Lymphoma.

Mars B. Van’t Veer, MD, PhD, Annelise Notenboom, PhD, Marius McKenzie, MD,PhD, Hanneke Kluin-Nelemans, MD,PhD, Rien van Oers, MD,PhD, Jose Zijlstra, MD, Daphne de Jong, MD,PhD, Pieter Sonneveld, MD,PhD, Anton Hagenbeek, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2734.
https://doi.org/10.1182/blood.V108.11.2734.2734
Published: 2006